F1000 Medicine Reports

Journal Information
ISSN / EISSN : 1757-5931 / 1757-5931
Published by: Faculty of 1000, Ltd. (10.3410)
Total articles ≅ 243
Current Coverage
PUBMED
PMC
Archived in
SHERPA/ROMEO
Filter:

Latest articles in this journal

, Anselm Kampik, Alois K. Dexl, Nicole Zimmermann, Adrian Glasser, Martin Baumeister, Thomas Kohnen
Published: 1 February 2013
F1000 Medicine Reports, Volume 5; https://doi.org/10.3410/m5-3

Abstract:
Advances in lens implant technology
, Robert A. Stockley
Published: 1 February 2013
F1000 Medicine Reports, Volume 5; https://doi.org/10.3410/m5-4

Abstract:
Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?
Suzanne H. Gage, ,
Published: 11 January 2013
F1000 Medicine Reports, Volume 5; https://doi.org/10.3410/m5-2

Abstract:
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population
David J Castle
Published: 11 January 2013
F1000 Medicine Reports, Volume 5; https://doi.org/10.3410/m5-1.1

Abstract:
FORMAL CORRECTION TO: Cannabis and psychosis: what causes what?
Joanna Togami, Elizabeth Brown,
Published: 1 November 2012
F1000 Medicine Reports, Volume 4; https://doi.org/10.3410/m4-21

Abstract:
Pelvic organ prolapse is a condition that can cause significant symptoms that affect a woman's quality of life. It is the result of defects in the supporting structures of the vagina and, depending on the location and size, can alter the functions of the organs contained within the female pelvis. Approximately 11% of women will undergo surgical intervention for their prolapse or for incontinence in their lifetime. Unfortunately, one third of these will require reoperation for failed procedures. Pelvic floor surgeons have sought to improve these outcomes. Based largely on the success of midurethral slings (MUS), transvaginal mesh has been implanted, and commercial kits developed with the intent of improving these outcomes. In 2008, the Food and Drug Administration (FDA) issued a Public Health Notification in response to possible increased adverse events associated with the use of mesh compared to traditional repairs. The 2011 update required that further study be conducted for the use of transvaginal mesh. In this article, we wish to discuss the background of mesh use and the evolution of the public health warnings, and focus on future prospects.
Corrigendum
Paul E. Holtzheimer, Helen S. Mayberg
Published: 1 November 2012
F1000 Medicine Reports, Volume 4; https://doi.org/10.3410/m4-22.1

Abstract:
CORRIGENDUM TO: Neuromodulation for treatment-resistant depression
Back to Top Top